Close Menu

NEW YORK (GenomeWeb) – Personal Genome Diagnostics has entered into a strategic collaboration with China's KingMed Diagnostics to use PGDx's Elio tissue complete assay to detect tumor mutational burden and other gene variants.

Separately, PGDx said it has also partnered with Merck as part of a phase II precision oncology study.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.